A Combination of Benmelstobart, Anlotinib, and Chemotherapy Improves Survival Rates in SCLC, Study Suggests
kalhh / Pixabay

A Combination of Benmelstobart, Anlotinib, and Chemotherapy Improves Survival Rates in SCLC, Study Suggests

  Advancing patient outcomes hinges on the development of targeted treatments, particularly in conditions with grim prognoses such as small cell lung cancer (SCLC), which typically has a life expectancy…

Continue Reading A Combination of Benmelstobart, Anlotinib, and Chemotherapy Improves Survival Rates in SCLC, Study Suggests

New Partnership will Improve and Accelerate Patient Involvement in Lung Cancer Research

Pattern.Org Pattern.org was created by the Rare Cancer Research Foundation, a nonprofit dedicated to improving the lives of rare cancer patients by accelerating research. Pattern.org specifically, is a branch of…

Continue Reading New Partnership will Improve and Accelerate Patient Involvement in Lung Cancer Research
There’s More Than One Way to Treat Cancer
Source: Pixabay.com

There’s More Than One Way to Treat Cancer

In an Article from AsiaOne.com, we meet John Ryan, retired nuclear reactor specialist who worked for the military when he was diagnosed with lung cancer. Now in remission he might…

Continue Reading There’s More Than One Way to Treat Cancer